Literature DB >> 15728403

Parkinson's disease: the first common neurological disease due to auto-intoxication?

A C Williams1, L S Cartwright, D B Ramsden.   

Abstract

Parkinson's disease may be a disease of autointoxication. N-methylated pyridines (e.g. MPP+) are well-established dopaminergic toxins, and the xenobiotic enzyme nicotinamide N-methyltransferase (NNMT) can convert pyridines such as 4-phenylpyridine into MPP+, using S-adenosyl methionine (SAM) as the methyl donor. NNMT has recently been shown to be present in the human brain, a necessity for neurotoxicity, because charged compounds cannot cross the blood-brain barrier. Moreover, it is present in increased concentration in parkinsonian brain. This increase may be part genetic predisposition, and part induction, by excessive exposure to its substrates (particularly nicotinamide) or stress. Elevated enzymic activity would increase MPP+-like compounds such as N-methyl nicotinamide at the same time as decreasing intraneuronal nicotinamide, a neuroprotectant at several levels, creating multiple hits, because Complex 1 would be poisoned and be starved of its major substrate NADH. Developing xenobiotic enzyme inhibitors of NNMT for individuals, or dietary modification for the whole population, could be an important change in thinking on primary and secondary prevention.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15728403     DOI: 10.1093/qjmed/hci027

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  16 in total

1.  Structural basis of substrate recognition in human nicotinamide N-methyltransferase.

Authors:  Yi Peng; Davide Sartini; Valentina Pozzi; Dennis Wilk; Monica Emanuelli; Vivien C Yee
Journal:  Biochemistry       Date:  2011-08-17       Impact factor: 3.162

2.  Protective Effects of 1-Methylnicotinamide on Aβ1-42-Induced Cognitive Deficits, Neuroinflammation and Apoptosis in Mice.

Authors:  Lili Fu; Caihong Liu; Liang Chen; Yangge Lv; Guoliang Meng; Mei Hu; Yan Long; Hao Hong; Susu Tang
Journal:  J Neuroimmune Pharmacol       Date:  2019-01-11       Impact factor: 4.147

Review 3.  Novel avenues of drug discovery and biomarkers for diabetes mellitus.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Yan Chen Shang; Jinling Hou
Journal:  J Clin Pharmacol       Date:  2010-03-10       Impact factor: 3.126

4.  Variable toxicological response to the loss of OXPHOS through 1-methyl-4-phenylpyridinium-induced mitochondrial damage and anoxia in diverse neural immortal cell lines.

Authors:  Elizabeth A Mazzio; Youssef I Soliman; Karam F A Soliman
Journal:  Cell Biol Toxicol       Date:  2010-04-18       Impact factor: 6.691

5.  Diabetes mellitus: channeling care through cellular discovery.

Authors:  Kenneth Maiese; Yan Chen Shang; Zhao Zhong Chong; Jinling Hou
Journal:  Curr Neurovasc Res       Date:  2010-02       Impact factor: 1.990

Review 6.  Cell Life versus cell longevity: the mysteries surrounding the NAD+ precursor nicotinamide.

Authors:  Faqi Li; Zhao Zhong Chong; Kenneth Maiese
Journal:  Curr Med Chem       Date:  2006       Impact factor: 4.530

Review 7.  Triple play: promoting neurovascular longevity with nicotinamide, WNT, and erythropoietin in diabetes mellitus.

Authors:  Kenneth Maiese
Journal:  Biomed Pharmacother       Date:  2008-02-20       Impact factor: 6.529

Review 8.  Mitochondrial permeability transition pore: a promising target for the treatment of Parkinson's disease.

Authors:  Md Zeeshan Rasheed; Heena Tabassum; Suhel Parvez
Journal:  Protoplasma       Date:  2016-01-29       Impact factor: 3.356

9.  Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity.

Authors:  Daniel Kraus; Qin Yang; Dong Kong; Alexander S Banks; Lin Zhang; Joseph T Rodgers; Eija Pirinen; Thomas C Pulinilkunnil; Fengying Gong; Ya-chin Wang; Yana Cen; Anthony A Sauve; John M Asara; Odile D Peroni; Brett P Monia; Sanjay Bhanot; Leena Alhonen; Pere Puigserver; Barbara B Kahn
Journal:  Nature       Date:  2014-04-10       Impact factor: 49.962

Review 10.  The vitamin nicotinamide: translating nutrition into clinical care.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Jinling Hou; Yan Chen Shang
Journal:  Molecules       Date:  2009-09-09       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.